UK gynaecological health start-up Daye and contract research organisation Lindus Health have teamed up to launch a clinical trial investigating a tampon capable of detecting human papillomavirus (HPV) and sexually transmitted infections (STIs).
The trial, overseen by Lindus Health, will enrol 375 patients across the UK and Italy to test the diagnostic tampon’s efficacy, safety and acceptability.
Female-founded Daye developed the diagnostic tampon for HPV and STI sample collection and analysis. According to London, UK-headquartered Daye, the tampon offers the advantage of collecting a bigger and more comprehensive sample compared with a conventional swab.
